Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
34MB |
Other (Supplemental Information)
14MB |
Item Type: | Article |
---|---|
Title: | Copy-number dosage regulates telomere maintenance and disease-associated pathways in neuroblastoma |
Creators Name: | Burkert, M., Blanc, E., Thiessen, N., Weber, C., Toedling, J., Monti, R., Dombrowe, V.M., de Biase, M.S., Kaufmann, T.L., Haase, K., Waszak, S.M., Eggert, A., Beule, D., Schulte, J.H., Ohler, U. and Schwarz, R.F. |
Abstract: | Telomere maintenance in neuroblastoma is linked to poor outcome and caused by either TERT activation or through alternative lengthening of telomeres (ALT). In contrast to TERT activation, commonly caused by genomic rearrangements or MYCN amplification, ALT is less well understood. Alterations at the ATRX locus are key drivers of ALT but only present in ∼50% of ALT tumors. To identify potential new pathways to telomere maintenance, we investigate allele-specific gene dosage effects from whole genomes and transcriptomes in 115 primary neuroblastomas. We show that copy-number dosage deregulates telomere maintenance, genomic stability, and neuronal pathways and identify upregulation of variants of histone H3 and H2A as a potential alternative pathway to ALT. We investigate the interplay between TERT activation, overexpression and copy-number dosage and reveal loss of imprinting at the RTL1 gene associated with poor clinical outcome. These results highlight the importance of gene dosage in key oncogenic mechanisms in neuroblastoma. |
Keywords: | Neuroblastoma, Telomere Maintenance, Alternative Lengthening of Telomeres, Copy-Number, Dosage Effects, Genome Instability, Imprinting, Whole-Genome Sequencing |
Source: | iScience |
ISSN: | 2589-0042 |
Publisher: | Elsevier / Cell Press |
Volume: | 27 |
Number: | 10 |
Page Range: | 110918 |
Number of Pages: | 1 |
Date: | 18 October 2024 |
Official Publication: | https://doi.org/10.1016/j.isci.2024.110918 |
Repository Staff Only: item control page